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Abstract
Background: Hypernatremia is a frequent occurrence among hospitalized patients. Severe hypernatremia is
associated with mortality rates of over 60 %. Extreme hypernatremia, defined as sodium levels >190 mmol/l, is a
rare occurrence. The literature on electrocardiographic changes occurring with this degree of hypernatremia is
extremely scarce. We report the case of an 11-year-old Sri Lankan girl who presented with sodium levels of 226
mmol/l following infusion with 3 % hypertonic saline who developed diffuse QT prolongation leading to fatal
ventricular tachycardia.
Case presentation: An 11-year-old Sri Lankan girl presented with fever, headache, vomiting, and altered level of
consciousness. Following admission she developed generalized tonic–clonic seizures and was intubated and
ventilated. She had a recent history of polyuria and polydipsia. Magnetic resonance imaging of her brain revealed
hydrocephalus due to possible craniopharyngioma. A ventriculoperitoneal shunt was inserted and she was infused
with 3 % hypertonic saline in an attempt to reduce intracranial pressure. The following day she became polyuric
and dehydrated with tachycardia and low blood pressure. Biochemistry revealed serum sodium of 226 mmol/l,
measured serum osmolality of 470 mOsm/kg, urine osmolality of 280 mOsm/kg, urine spot sodium of 116 mmol/l,
blood urea of 8.1 mmol/l, and blood glucose of 8.5 mmol/l. Her serum potassium, calcium, and magnesium levels
were normal. Extreme hypernatremia due to infusion of 3 % hypertonic saline in the background of cranial diabetes
insipidus was considered. She was managed aggressively with 5 % dextrose infusion and clear water via nasogastric
feeding to correct the fluid deficit of 7 liters over 36 hours. Her sodium levels dropped to 160 mmol/l the following
day. However, she developed electrocardiographic changes with widespread gross QT prolongation with ST
segment deviations followed by fatal ventricular tachycardia.
Conclusions: Extreme hypernatremia is rare, and the literature on electrocardiographic changes occurring at such
high levels of sodium is scarce. At present there are no established guidelines on rate and mode of correction of
such high sodium levels. This case highlights the electrocardiographic changes observed during extreme
hypernatremia, controversies in managing increased intracranial pressure with hypertonic saline, and dilemmas
encountered in managing extreme hypernatremia.
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Background
Hypernatremia is a frequent electrolyte abnormality ob-
served in hospitalized patients. It is most frequently
caused by excess water loss and less frequently by in-
creased sodium intake. Severe hypernatremia (>160
mmol/l) is a serious condition associated with high mor-
tality of >60 % [1]. Cases reported on extreme hyperna-
tremia (>190 mmol/l) are few and literature on
electrocardiographic (ECG) changes occurring with this
degree of hypernatremia are scarce. Current literature
on the management of hypernatremia recommends slow
correction in chronic hypernatremia with a 10 to 12
mmol/l reduction in order to prevent adverse neuro-
logical sequelae such as cerebral edema [2]. However,
there are many controversies in the rate of correction in
patients with extreme hypernatremia as persistent hyper-
natremia is associated with high mortality [3]. Manage-
ment in such extreme cases poses a therapeutic* Correspondence: Maulee_80@yahoo.com
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challenge with some patients achieving successful out-
comes with fluid therapy and others with dialysis.
We report the case of a girl with sodium levels of 226
mmol/l following infusion with 3 % hypertonic saline in
an attempt to reduce intracranial pressure who devel-
oped ECG changes of diffuse QT prolongation and ST
segment deviations leading to fatal ventricular tachycar-
dia (VT).
Case presentation
An 11-year-old Sri Lankan girl presented with a 2-day
history of fever, headache, vomiting, and altered level of
consciousness. She had been experiencing polyuria and
polydipsia during the past 2 weeks. There was no history
of chronic headaches, visual disturbances, respiratory
symptoms, or abdominal symptoms. She was not known
to be diabetic. An examination revealed an unwell-
looking febrile girl. Her height was 140 cm (25th centile)
and her weight was 25 kg (3rd centile). There was no
evidence of neck stiffness or positive Kernig’s sign. Fol-
lowing admission she developed generalized tonic–
clonic seizures which required intubation and ventila-
tion. Random blood glucose and electrolyte panel in-
cluding sodium, potassium, calcium, and magnesium
were normal. She was empirically started on antibiotics
administered intravenously for possible meningitis. Mag-
netic resonance imaging revealed gross hydrocephalus
with suprasellar mass most likely due to craniopharyn-
gioma (Figs. 1, 2, and 3). A ventriculoperitoneal shunt
was inserted and she was started on 3 % hypertonic sa-
line to reduce intracranial pressure. Her basal serum so-
dium levels were 140 mmol/l and she was commenced
on a dose of 5 ml/kg 8 hourly, aiming to increase her so-
dium levels to 160 to 170 mmol/l. Her serum electro-
lytes were monitored 8 hourly. Her sodium levels rose to
163 mmol/l after the first 24 hours. It was decided to re-
peat another dose of 3 % hypertonic saline. However,
during the latter part of the day she became polyuric
and dehydrated. Her blood pressure was 80/60 and pulse
rate was 130 beats per minute. She was hydrated with
boluses of normal saline and commenced on hydrocorti-
sone replacement administered intravenously. As her
blood pressure failed to stabilize she was started on ino-
tropic support with noradrenaline and dobutamine infu-
sions. Her serum sodium levels were 226 mmol/l and
further doses of 3 % hypertonic saline were stopped im-
mediately. Other biochemical investigations were as fol-
lows: serum potassium 3.8 mmol/l (3.5 to 5.0 mmol/l),
blood urea 8.1 mmol/l (2.5 to 8.0 mmol/l), serum cre-
atinine 76 μmol/l (70 to 120 μmol/l), random blood glu-
cose 8.5 mmol/l, serum ionized calcium 1.12 mmol/l
(1.05 to 1.3 mmol/l), and serum magnesium 0.8 mmol/l
(0.75 to 0.95 mmol/l). Her measured serum osmolality
was 470 mOsm/kg with a urine osmolality of 280
Fig. 1 Magnetic resonance imaging T1-weighted pre-contrast axial
image showing suprasellar mass suggestive of craniopharyngioma
Fig. 2 Magnetic resonance imaging T2-weighted pre-contrast axial
image of the lesion
Arambewela et al. Journal of Medical Case Reports  (2016) 10:272 Page 2 of 5
mOsm/kg. There was no discrepancy between measured
and calculated serum osmolalities. Her urine spot so-
dium was elevated at 116 mmol/l. A urine spot sodium
of >100 mmol/l can be seen in hypernatremia following
ingestion of salt or infusion of 3 % hypertonic saline.
Considering the clinical and biochemical factors, hyper-
natremia in our patient can be attributed to infusion of
3 % hypertonic saline in the background of cranial dia-
betes insipidus.
As we considered a sodium level of 226 mmol/l not
compatible with life it was decided to correct her so-
dium levels rapidly. She was treated with an immediate
dose of desmopressin 400 micrograms administered or-
ally and hydrated with 5 % dextrose administered intra-
venously and clear water via nasogastric feeding at a rate
of 190 ml/hour to replace the fluid deficit of 7 liters over
36 hours. Her polyuria settled and her serum sodium
levels dropped to 160 mmol/l on the following day.
However, her cardiac status became unstable and a 12-
lead ECG showed diffuse prolongation of QT intervals,
ST depressions in leads V1 to V2, ST elevation in V3,
and VT in V4 to V5 (Fig. 4). An urgent echocardiogram
was planned but she developed VT and went into car-
diac arrest. In spite of defibrillation and subsequent re-
suscitation she died.
Discussion
Hypernatremia defined as serum sodium levels >145
mmol/l, is associated with increased morbidity and mor-
tality. Severe hypernatremia is defined as sodium levels
>160 mmol/l and extreme hypernatremia as >190 mmol/l.
Manifestations of hypernatremia vary from nonspecific
central nervous system symptoms such as nausea, vomit-
ing, muscle weakness, restlessness, irritability, and lethargy
to confusion, nystagmus, seizures, myoclonic jerks, and
even death. The level of consciousness is correlated with
the severity of hypernatremia. Severe symptoms are likely
to occur with acute increases in plasma sodium levels or
at concentrations greater than 160 mmol/l [1]. Hyperna-
tremia can cause brain shrinkage, resulting in vascular
rupture and intracranial bleeding.
Cases of extreme hypernatremia in humans have been
rarely reported and the literature describing ECG changes
is scarce. Sodium is the most abundant extracellular cation
and its current determines the depolarization and ampli-
tude of the action potential. In Gibson and colleague’s [4]
study conducted on the effects of acute alterations in the
blood sodium on ECG changes in dogs, rapid induction of
hypernatremia showed QT prolongation and decrease in P
and QRS amplitude as was seen in our patient. In Gibson
and colleague’s study [4], the reduction in the P and QRS
amplitude were related to alterations in blood conductivity
with a short circuiting effect on myocardial potentials. Pro-
longation of the QT interval is an indication of an increase
in the duration of the action potential due to the high
extracellular sodium levels causing an increase in the trans-
membrane gradient. In a further case of extreme hyperna-
tremia in which a 29-year-old woman had serum sodium of
154 mmol/l, ECG changes of sinus tachycardia, short PR
interval, and diffuse ST depressions were observed [5]. A
study performed by Fisher et al. [6] demonstrated that
hypernatremia following acute subarachnoid hemorrhage
was associated with adverse cardiac outcomes such as left
ventricular contractile dysfunction, elevated cardiac en-
zymes, pulmonary edema, and death. The actual patho-
physiology of hypernatremia on cardiac dysfunction is
unknown. It is, however, hypothesized that increased extra-
cellular sodium causes more calcium to exit the cell via so-
dium calcium exchanger on the sarcolemma. This results
in reduced levels of intracellular calcium levels available for
cardiac myocyte contraction causing a negative inotropic
effect. Considering these facts, extreme hypernatremia
would have been the most likely culprit for the fatal
arrhythmia that occurred in our patient.
Our patient was given an infusion of 3 % hypertonic
saline in an attempt to reduce intracranial pressure. In
the last decade many studies have been done on the ef-
fects of 3 % hypertonic saline in intracranial pressure in
traumatic or non-traumatic brain injury in experimental
and human models [7, 8]. Side effects include rebound
increased intracranial hypertension, renal impairment,
subarachnoid hemorrhage, central pontine myelinolysis,
high urinary water losses, and masking of diabetes insi-
pidus. Further studies have shown that the prognosis in
children with increased intracranial pressure having
Fig. 3 Magnetic resonance imaging post-contrast axial image of
the lesion
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higher levels of sodium within the range of 150 to 170
mmol/l and higher levels of serum osmolality of 300 to
340 mOsm/kg appear to be better than normal to low
levels of serum soidum and osmolality. However, no pa-
tient with a serum sodium >180 mmol/l has had a good
outcome [9]. There is Class II evidence supporting the
use of hypertonic saline for the acute treatment of severe
pediatric traumatic brain injury associated with in-
creased intracranial hypertension and Class III evidence
to support its use as a continuous infusion [10]. How-
ever, there are insufficient data to determine when to
initiate, the duration of treatment, and target sodium
concentrations. Further studies are required to resolve
these concerns.
Management of such extreme cases of hypernatremia
poses a therapeutic challenge. Hypernatremia initially
causes fluid to move out of the brain leading to cerebral
contraction causing alterations in mental status. To
counteract this, the brain initially takes up electrolytes
to reduce the contraction of cerebral volume. This is
followed by a slower adaptive phase in which there is ac-
cumulation of organic osmolytes. Subsequently, the
brain volume is restored as the solutes within the brain
cells drag water into the cells and thereby restore the
cerebral volume within 1 to 3 days [11]. When correct-
ing hypernatremia, awareness regarding these acute and
chronic stages is necessary as major changes in osmolal-
ity can eventually lead to cerebral edema.
Most literature published on the management of
chronic hypernatremia recommends a slow correction
rate of 10 to 12 mmol/24 hours [2]. However, no prospect-
ive studies validate such recommendations. Alshayeb et al.
carried out a study on correction rates in severe hyperna-
tremia among hospitalized patients; they concluded that
slower correction rates were associated with high mortal-
ity [3]. Cases published on extreme hypernatremia are
scarce and the rate of correction and modes of correction
differ. Most such cases with successful outcomes have
achieved more rapid corrections without neurological se-
quelae [12–16]. A faster correction rate has a risk of caus-
ing cerebral edema and a slower rate will promote
persistent hypernatremia. Both scenarios are associated
with high mortality. However, in the cases with positive
outcome, high correction rates were used based on the
theory that extreme hypernatremia is not compatible with
life. The therapeutic modes used to achieve these higher
correction rates differ: fluid therapy, hemodialysis, and
peritoneal dialysis.
In our patient, extreme hypernatremia (sodium level
of 226 mmol/l) was thought to be acute due to infusion
of 3 % hypertonic saline plus underlying cranial diabetes
insipidus. Correction was done initially with clear water
through nasogastric tube and 5 % dextrose to achieve
the fluid deficit of 7 liters during the first 36 hours. Her
serum sodium dropped to 160 mmol/l on the following
day and fluid replacement was changed to 0.45 % normal
saline with clear water at a lower rate. Several cases of
extreme hypernatremia have been managed successfully
with fluid therapy without any adverse neurological se-
quelae [12, 15]. However, this was not the case in our
patient who succumbed to a fatal arrhythmia. The rate
of water replacement in severe hypernatremia is contro-
versial and the available data are insufficient to enable
consistent recommendations in such extreme cases.
Even though dialysis is not recommended in present
guidelines on hypernatremia, it is believed to have a
beneficial role in managing cases of acute extreme
hypernatremia. Correction with fluid would require large
volumes and longer duration, whereas with dialysis the
duration of treatment can be curtailed. Furthermore,
dialysis has beneficial effects in scenarios complicated
with cardiopulmonary or renal disorders. The rate of
correction can be adjusted by changing the concentra-
tion of sodium in the dialysate. Few cases of
Fig. 4 Electrocardiogram showing tachycardia, small complexes, QT prolongation, ST segment deviations, and ventricular tachycardia in V4
and V5
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hypernatremia corrected with hemodialysis have been
reported without any neurological complications despite
the faster correction rate [14, 16]. A safer approach in
chronic hypernatremia would be continuous renal re-
placement therapy where sodium levels can be drawn
every hour, and the fluid rate in addition to dialysate
concentration can be changed easily [16]. Our patient
was initially on inotropic support. However, with fluid
resuscitation the inotropes were being gradually with-
drawn. Whether she would have benefited from dialysis
and, if so, from what form of dialysis, are questions to
ponder on.
Conclusions
Extreme hypernatremia is a rare occurrence and litera-
ture on ECG changes in such patients is scarce. Our pa-
tient presented with acute extreme sodium levels of 226
mmol/l following infusion with 3 % hypertonic saline in
an attempt to reduce intracranial pressure. Even though
rapid correction of sodium was done via fluid therapy
she developed fatal arrhythmias. ECG revealed gross dif-
fuse QT prolongation with ST depressions and eleva-
tions which ultimately led to VT. This case highlights
the rare ECG manifestations in extreme hypernatremia,
controversies in target sodium levels when attempting to
reduce intracranial pressure with hypertonic saline, and
dilemmas in managing extreme hypernatremia.
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